Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00064376
Status:
COMPLETED
Last Update Posted:
2018-01-29
First Post:
2003-07-08
Brief Title:
Paricalcitol in Treating Patients With Myelodysplastic Syndrome
Sponsor:
Cedars-Sinai Medical Center
Organization:
Cedars-Sinai Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| chronic myelomonocytic leukemia | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| refractory anemia with excess blasts in transformation | View |
| refractory anemia with excess blasts | View |
| refractory anemia with ringed sideroblasts | View |
| refractory anemia | View |